CNTB: Connect Pharma O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati
Connect Biopharma dermatitis va yallig'lanishga qarshi immunoterapiyani AQSh va Xitoyda joriy etish orqali daromad olishni rejalashtirmoqda. PEG koeffitsiyentining o'zgarishi kompaniyaning bozor qiymatini foyda o'sishiga nisbatan vizuallashtiradi, bunda 0.00 ushbu metrikaning joriy qiymatini ko'rsatadi. Daromadlar autoimmun patologiyalarni davolashdagi innovatsiyalarga asoslangan, garchi Vashington va Pekin o'rtasidagi tartibga soluvchi o'zgarishlar operatsion qiyinchiliklarni keltirib chiqarayotgan bo'lsa-da.
Connect Biopharma (CNTB) kompaniyasi koʻrsatkichlari kesimi va tahlili
- aksiya narxi va baholash bo'yicha konsensus prognoz:
- bozor kapitallashuvi haqida ma'lumot:
- kompaniyaning balans qiymati tafsilotlari:
- emitentning kredit yuki va likvidlik ko'rsatkichlari:
Umumiy qarzning kapitalga nisbati Connect Biopharma|CNTB - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati ko'rsatkichi connectbiopharm.com|CNTB - Kompaniyaning jamlangan qarzlari|Balans qiymatiga qarzlar Connect Pharma|CNTB - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli majburiyatlari Connect Biopharma|Shoshilinch likvidlik connectbiopharm.com
- biznes foydasi va investitsiya koeffitsiyentlari ma'lumotlari:
CNTB - Kompaniyaning sof foydasi|Sof foyda prognozi Connect Biopharma|CNTB - Narxning foydaga nisbati|Narxning kelajakdagi foydaga nisbati connectbiopharm.com|CNTB - PEG multiplikatori|Kompaniya qiymatining foizlar, soliqlar va amortizatsiyadan oldingi foydaga nisbati Connect Pharma|CNTB - EBITDA operatsion foydasi|So'nggi 12 oy davomida bir aksiya uchun sof foyda Connect Biopharma|CNTB - So'nggi 12 oy davomida bir aksiya uchun sof foyda|So'nggi o'n ikki oy davomida bir aksiya uchun foydaning yillik o'sish sur'ati connectbiopharm.com|CNTB - Bu yil bir aksiya uchun sof foyda o'sishi|Keyingi yilda bir aksiya uchun foydaning kutilayotgan dinamikasi Connect Biopharma
Kompaniyaning umumiy tahlili:CNTB - Connect Biopharma Holdings
PEG koeffitsiyenti P/E ko'rsatkichini foyda o'sish sur'atlari bilan solishtiradi. P/E-o'sish grafigini tahlil qilish orqali investor qiymat birdan past bo'lganda past baholangan aktivlarni aniqlaydi. Ushbu metrika kelajakdagi o'sishning bir birligi uchun xarajatni o'lchaydi va sof foyda tebranishlariga sezgir bo'lib qoladi. Connect Biopharma (CNTB) uchun ushbu ko'rsatkich bozor kapitalizatsiyasining klinik sinovlar natijalariga bog'liqligi sababli juda muhimdir. Dermatologiya sohasidagi muvaffaqiyatsizlik xatarlari hisoblangan rivojlanish potentsialiga jiddiy zarar yetkazishi mumkin.
Raqobatdosh kompaniyalar
ARGX (argenx N.V.) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori BNTX (BioNTech Group)|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Abivax (ABVX)|ADMA - Narxning foydaga va o‘sish sur’atiga nisbati|protagonist-inc.com (PTGX) - Narx-foyda va o‘sish multiplikatori|Immunovant (IMVT) - Narxning foydaga va o‘sish sur’atiga nisbati|Narx-foyda va o‘sish multiplikatori Kiniksa Pharmaceuticals, Ltd.|Narx-foyda va o‘sish multiplikatori GRFS|PEG multiplikatori Adaptive Biotechnologies Inc.|Narxning foydaga va o‘sish sur’atiga nisbati Celldex Therapeutics (CLDX)|auriniapharma.com - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|PEG multiplikatori BCRX (BioCryst Pharmaceuticals)|Vera Therapeutics Inc (VERA) - O‘sish sur’atiga tuzatilgan narx-foyda|Dianthus Pharma - PEG multiplikatori|Pharvaris Pharma (PHVS) - Narx-foyda va o‘sish multiplikatori|abcellera.com (ABCL) - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atiga tuzatilgan narx-foyda tourmalinebio.com (TRML)|Narxning foydaga va o‘sish sur’atiga nisbati Precigen|O‘sishni hisobga olgan narx-foyda koeffitsiyenti PHAR (Pharming Group NV)|Narxning foydaga va o‘sish sur’atiga nisbati Nektar (NKTR)|Upstream Pharma - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|PEG multiplikatori ZBIO (Zenas Biopharma Inc)|immunome.com (IMNM) - O‘sish sur’atiga tuzatilgan narx-foyda|Gossamer Bio - PEG multiplikatori|KalVista Pharma (KALV) - Narx-foyda va o‘sish multiplikatori|SEPN (Septerna Corp) - Narx-foyda va o‘sish multiplikatori|PVLA: Kompaniya qiymatining foyda o‘sish sur’atiga nisbati|Narx-foyda va o‘sish multiplikatori SVRA|RIGL: O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori ANAB|Narxning foydaga va o‘sish sur’atiga nisbati ATXS (Astria Therapeutics Inc)|PEG multiplikatori ENGN (enGene Bio)|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati rapt.com (RAPT)|JBIO - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atiga tuzatilgan narx-foyda aclaristx.com|Kyverna Therapeutics, Inc. (KYTX) - Narxning foydaga va o‘sish sur’atiga nisbati|Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati TLSA (Tiziana Life Sciences Ltd.)|CABA (Cabaletta Bio, Inc) - PEG multiplikatori|VTYX: O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori THTX|PEG multiplikatori avalotx.com (AVTX)|Narxning foydaga va o‘sish sur’atiga nisbati Eledon Pharmaceuticals, Inc. ELDN|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti AGEN|CLYM - Narxning foydaga va o‘sish sur’atiga nisbati|zurabio.com (ZURA) - Narx-foyda va o‘sish multiplikatori|ATYR: PEG multiplikatori|Adagene Inc. (ADAG) - PEG multiplikatori|IMA (ImageneBio) - PEG multiplikatori|Narx-foyda va o‘sish multiplikatori Shattuck Therapeutics (STTK)|Narxning foydaga va o‘sish sur’atiga nisbati Equillium, Inc. (EQ)|immunic-therapeutics.com - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|Atara Bio - Narx-foyda va o‘sish multiplikatori|Kompaniya qiymatining foyda o‘sish sur’atiga nisbati IFRX (InflaRx NV)|X4 Pharmaceuticals, Inc. - PEG multiplikatori|ACET: Narxning foydaga va o‘sish sur’atiga nisbati|celularity.com (CELU) - Narxning foydaga va o‘sish sur’atiga nisbati|Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati INMB (INmune Bio Corporation)|BRNS (Barinthus Biotherapeutics) - PEG multiplikatori|KZR: O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori SABS|PEG multiplikatori Akari Therapeutics PLC (AKTX)|Narxning foydaga va o‘sish sur’atiga nisbati Enlivex Therapeutics Ltd. ENLV|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti QTTB|GOVX - Narxning foydaga va o‘sish sur’atiga nisbati|edesabiotech.com (EDSA) - Narx-foyda va o‘sish multiplikatori|IBIO: PEG multiplikatori|Carisma Therapeutics Inc. (CARM) - PEG multiplikatori|Narx-foyda va o‘sish multiplikatori XTLB|BOLT: O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori HCWB|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati aptevotherapeutics.com|Narxning foydaga va o‘sish sur’atiga nisbati AIM ImmunoTech AIM|ADTX - Narx-foyda va o‘sish multiplikatori|GRI - Narxning foydaga va o‘sish sur’atiga nisbati|XORTX Corp (XRTX) - Narx-foyda va o‘sish multiplikatori|HIND (Vyome Holdings Inc) - Narx-foyda va o‘sish multiplikatori|revbiosciences.com (REVB) - PEG multiplikatori|Narxning foydaga va o‘sish sur’atiga nisbati Indaptus Therapeutics, Inc.|O‘sishni hisobga olgan narx-foyda koeffitsiyenti SCNI (Scinai Immunotherapeutics Ltd)|PEG multiplikatori CALI|AFMD - O‘sish sur’atiga tuzatilgan narx-foyda|PEG multiplikatori ALLK (Allakos)|HOOK - Narx-foyda va o‘sish multiplikatori|IGMS - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atiga tuzatilgan narx-foyda iTeos Therapeutics Inc|Ocean Bio (OCEA) - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sishni hisobga olgan narx-foyda koeffitsiyenti TCBP|Narxning foydaga va o‘sish sur’atiga nisbati Third Harmonic Bio
